Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens
ChemBioChem · 2023
DOI: 10.1002/cbic.202200805 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, 2023. Verfasst von Lixin Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, 66 Gongchang Lu, Guangming District, Shenzhen, 518107, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 139 Literaturangaben. Gefördert von: Sun Yat-sen University, Basic and Applied Basic Research Foundation of Guangdong Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Cancer vaccines are based on a vaccinology strategy whereby the patient's immune system is harnessed to induce a specific immune response to kill cancer cells and comprises two categories: prophylactic and therapeutic. Glycoprotein mucin 1 (MUC1), which is overexpressed and poorly glycosylated on cancer cells, is one of the most promising candidates for the development of new cancer vaccines. However, it should be noted that mucin‐like glycopeptides are poorly immunogenic and unable to elicit effective and long‐lasting immune responses. Therefore, MUC1‐derived tumor antigens need to be conjugated with immune activators. This review focuses on the synthesis of MUC1 glycopeptides, provides an overview of recently advanced designs of vaccines based on MUC1, and compares the advantages and disadvantages of the various strategies devised to date.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, 66 Gongchang Lu, Guangming District, Shenzhen, 518107, China.
ORCID-Profile: Hui Cai
Förderung
- Sun Yat-sen University
- Basic and Applied Basic Research Foundation of Guangdong Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Yin, L., Zhou, Y., Hong, S., Ding, F., & Cai, H. (2023). Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens. ChemBioChem. https://doi.org/10.1002/cbic.202200805
Vancouver
Yin L, Zhou Y, Hong S, Ding F, Cai H. Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens. ChemBioChem. 2023. doi:10.1002/cbic.202200805
BibTeX
@article{Yin2023,
author = {Yin, Lixin and Zhou, Yang and Hong, Sheng and Ding, Feiqing and Cai, Hui},
title = {Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens},
journal = {ChemBioChem},
year = {2023},
doi = {10.1002/cbic.202200805}
}
EUVIMED